Sté Tunisienne des Maladies Respiratoires et d'Allergologie
Cercle des Bureaux - Appartement B 5-3 . 1082 Centre urbain Nord Tunis
![#ERScongress – [Abstract Only] Phase 2 trial of the DPP-1 inhibitor Brensocatib in bronchiectasis](/media/k2/items/cache/1ba6f013b03d3119f460bad3db0fbe5d_L.jpg)
#ERScongress – [Abstract Only] Phase 2 trial of the DPP-1 inhibitor Brensocatib in bronchiectasis
Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis – New England Journal of Medicine Commentary on Twitter Original Article: Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis (WILLOW Trial) #ERScongress — NEJM (@NEJM) September 7, 2020
The post #ERScongress – [Abstract Only] Phase 2 trial of the DPP-1 inhibitor Brensocatib in bronchiectasis appeared first on Links Medicus.
-
Taille de police
Réduire la taille de la police
Augmenter la taille de police
About Author
Dernier de Zouhair Souissi
- Review: Lung Transplantation
- RCT: ICS-Formoterol and ICS-SABA Reduce Severe Asthma Exacerbations Compared With SABA Alone
- ATS Guideline: Evaluation and Management of Obesity Hypoventilation Syndrome
- RCT: Telehealth-Delivered Early Palliative Care Equivalent to In-Person Care in Advanced Lung Cancer
- Summary: Perioperative Management of Patients Taking Direct Oral Anticoagulants
Laissez un commentaire
Assurez-vous d'entrer toutes les informations requises, indiquées par un astérisque (*). Le code HTML n'est pas autorisé.